Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a radical hysterectomy (removal of the uterus and surrounding tissue) and pelvic lymph node removal, with a confirmed diagnosis of cervical cancer
- People whose cervical cancer was classified as stage IB1 to IIA2 using the 2014 FIGO cervical cancer staging system
- People who received post-surgery radiation therapy or chemotherapy combined with radiation, starting within one week of admission to the trial's treating hospital (ZJPPH)
- People with a general health and activity level rated 0 to 2 on a standard medical performance scale, meaning they are able to carry out daily activities with little to no limitation
- People who had no cancer treatments before their radical surgery
- People whose recent blood test results (taken within 7 days of enrolling) show that bone marrow, liver, kidney, and heart function all fall within acceptable ranges set by the trial (confirm specific numbers with trial site)
- People who are not known to be allergic to platinum-based chemotherapy drugs such as cisplatin or carboplatin, or to similar compounds
- People who are willing to follow the trial's requirements, including accepting nutritional therapy as part of the study
- People who have signed an informed consent form agreeing to participate
Who may not be able to join:
- People whose medical scans have poor image quality or visible interference around a specific spinal muscle region used in the study's measurements (the L3 psoas area)
- People who have previously received chemotherapy or radiation therapy
- People whose bone marrow, liver, or kidney function is too poor to safely tolerate chemotherapy or radiation therapy
- People who are currently taking part in another clinical trial
- People who are pregnant, breastfeeding, or not using contraception
- People with serious or uncontrolled medical conditions, which may include active uncontrolled infection, heart failure, unstable chest pain, irregular heartbeat, or significant mental health or social circumstances that would make it difficult to follow the study requirements
- People who have had another active cancer diagnosis within the past five years
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yongshi Jia, M.D., Zhejiang Provincial People's Hospital
Phone: +86-571-85893638
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Construction and Validation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.